Nektar Therapeutics (NKTR) announced that it has signed two deals to advance BEMPEG combos — one with Merck (MRK) and the other with SFJ Pharmaceuticals, explains John McCamant, biotech expert and …

More Nektar Gets Support from Innovative Collaborations Videos